Harmony Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Harmony Biosciences Holdings
HRMY Stock  USD 37.38  0.04  0.11%   
Harmony Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Harmony Biosciences' valuation are provided below:
Gross Profit
641.7 M
Profit Margin
0.2248
Market Capitalization
2.2 B
Enterprise Value Revenue
1.9964
Revenue
825.9 M
We have found one hundred twenty available fundamental trends for Harmony Biosciences, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Harmony Biosciences regular market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 1.8 B in 2026. Enterprise Value is likely to rise to about 2.5 B in 2026

Harmony Biosciences Total Revenue

863.04 Million

Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 55.9 M, Net Interest Income of 988.5 K or Depreciation And Amortization of 16.4 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0 or PTB Ratio of 2.81. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Harmony Stock
Check out the analysis of Harmony Biosciences Correlation against competitors.

Harmony Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.2 B1.1 B388.9 M
Slightly volatile
Short and Long Term Debt Total157.6 M163.3 M252.5 M
Slightly volatile
Other Current Liabilities86.2 M165.3 M49.8 M
Slightly volatile
Total Current Liabilities211.4 M201.3 M64.9 M
Slightly volatile
Other Liabilities1.5 M1.8 M1 M
Slightly volatile
Property Plant And Equipment Net4.1 M3.9 M1.9 M
Slightly volatile
Accounts Payable16.6 M15.8 M5.3 M
Slightly volatile
Cash547 M521 M195 M
Slightly volatile
Non Current Assets Total507.1 M482.9 M144.5 M
Slightly volatile
Non Currrent Assets Other234.8 M223.6 M39.5 M
Slightly volatile
Other Assets105.3 M100.3 M28.4 M
Slightly volatile
Cash And Short Term Investments269.4 M537.3 M187.6 M
Slightly volatile
Common Stock Shares Outstanding64.3 M66.6 M54.9 M
Slightly volatile
Liabilities And Stockholders Equity1.2 B1.1 B388.9 M
Slightly volatile
Non Current Liabilities Total161.1 M189.7 M81.2 M
Slightly volatile
Other Current Assets12.9 M25.1 M8.5 M
Slightly volatile
Total Liabilities260.6 M391.1 M139.5 M
Slightly volatile
Property Plant And Equipment Gross1 M844.2 K1.3 M
Slightly volatile
Total Current Assets699.4 M666.1 M244.4 M
Slightly volatile
Capital Stock855900195.8 M
Slightly volatile
Non Current Liabilities Other1.7 M2.2 M1 M
Slightly volatile
Net Working Capital488 M464.8 M179.5 M
Slightly volatile
Common Stock800900982
Slightly volatile
Property Plant Equipment837.9 K515.7 K1.2 M
Slightly volatile
Long Term Debt185.8 M187.5 M133.4 M
Slightly volatile
Intangible Assets144.8 M130.3 M100.9 M
Slightly volatile
Common Stock Total Equity800900982
Slightly volatile
Long Term Debt Total153 M170.7 M189.4 M
Slightly volatile
Capital Surpluse696.9 M776.4 M622.2 M
Slightly volatile
Deferred Long Term Liabilities169.6 K190.8 K208.3 K
Slightly volatile
Current Deferred Revenue95 M141.7 M70.6 M
Slightly volatile
Short and Long Term Debt9.7 M18.7 M5 M
Slightly volatile
Short Term Debt10.4 M20.2 M6.2 M
Slightly volatile

Harmony Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization16.4 M27.7 M8.8 M
Slightly volatile
Selling General Administrative69.4 M126.9 M43.3 M
Slightly volatile
Selling And Marketing Expenses74.3 M127.6 M47.6 M
Slightly volatile
Other Operating Expenses632.6 M602.5 M197.2 M
Slightly volatile
Research Development176.1 M167.7 M51 M
Slightly volatile
Cost Of Revenue189.4 M180.3 M48.1 M
Slightly volatile
Total Operating Expenses443.3 M422.2 M149.2 M
Slightly volatile
Reconciled Depreciation16.4 M27.7 M8.8 M
Slightly volatile
Preferred Stock And Other Adjustments21.5 M24.2 M26.4 M
Slightly volatile
Interest Income22.4 M21.3 M4.9 M
Slightly volatile

Harmony Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation51.4 M49 M14.2 M
Slightly volatile
Begin Period Cash Flow193.7 M358.7 M153.3 M
Slightly volatile
Depreciation17.1 M27.7 M9.1 M
Slightly volatile
Capital Expenditures620.3 K1 M1 M
Slightly volatile
Change To Operating Activities11.1 M14.8 M6.2 M
Slightly volatile
End Period Cash Flow547.3 M521.3 M195.5 M
Slightly volatile
Dividends Paid4.3 M4.5 M98.1 M
Slightly volatile
Cash And Cash Equivalents Changes8.1 M8.5 M135.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.993.15234
Slightly volatile
Days Sales Outstanding89.0848.76174
Slightly volatile
Average Payables1.7 M2.2 M1.9 M
Slightly volatile
Stock Based Compensation To Revenue0.06510.06850.9953
Slightly volatile
Capex To Depreciation0.05220.0553.8862
Slightly volatile
EV To Sales2.582.71241
Slightly volatile
Inventory Turnover11.3419.617.591
Slightly volatile
Days Of Inventory On Hand18.319.27158
Slightly volatile
Payables Turnover12.2210.277.6755
Slightly volatile
Sales General And Administrative To Revenue0.170.183.65
Slightly volatile
Research And Ddevelopement To Revenue0.220.236.8974
Slightly volatile
Capex To Revenue0.00180.00190.0158
Slightly volatile
Cash Per Share7.767.393.4417
Slightly volatile
Days Payables Outstanding34.9536.791.6 K
Slightly volatile
Income Quality0.961.361.0887
Pretty Stable
Intangibles To Total Assets0.120.130.4852
Slightly volatile
Current Ratio5.023.88.0397
Slightly volatile
Receivables Turnover5.587.753.9909
Slightly volatile
Graham Number14.7423.2410.854
Slightly volatile
Capex Per Share0.01550.02330.0209
Slightly volatile
Revenue Per Share11.8711.313.6464
Slightly volatile
Interest Debt Per Share4.194.025.1495
Slightly volatile
Debt To Assets0.20.212.0953
Slightly volatile
Short Term Coverage Ratios14.7815.5642.4746
Slightly volatile
Operating Cycle64.6368.03329
Slightly volatile
Days Of Payables Outstanding34.9536.791.6 K
Slightly volatile
Long Term Debt To Capitalization0.220.230.6319
Slightly volatile
Total Debt To Capitalization0.240.250.6368
Slightly volatile
Quick Ratio4.973.768.0171
Slightly volatile
Net Income Per E B T1.140.870.961
Pretty Stable
Cash Ratio4.152.987.409
Slightly volatile
Days Of Inventory Outstanding18.319.27158
Slightly volatile
Days Of Sales Outstanding89.0848.76174
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.211.141.0778
Pretty Stable
Fixed Asset Turnover372190200
Slightly volatile
Debt Ratio0.20.212.0953
Slightly volatile
Price Sales Ratio2.993.15234
Slightly volatile
Asset Turnover0.430.640.2819
Slightly volatile
Gross Profit Margin0.630.70.7486
Very volatile

Harmony Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B1.8 B2 B
Slightly volatile
Enterprise Value2.5 B1.9 B2.1 B
Pretty Stable

Harmony Fundamental Market Drivers

Forward Price Earnings8.3963
Cash And Short Term Investments467.2 M

Harmony Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue141.7 M95 M
Total Revenue821.9 M863 M
Cost Of Revenue180.3 M189.4 M
Stock Based Compensation To Revenue 0.07  0.07 
Sales General And Administrative To Revenue 0.18  0.17 
Research And Ddevelopement To Revenue 0.23  0.22 
Revenue Per Share 11.31  11.87 
Ebit Per Revenue 0.24  0.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY